Biomerica, Inc. (BMRA) financial statements (2020 and earlier)

Company profile

Business Address 17571 VON KARMAN AVENUE
IRVINE, CA 92614
State of Incorp. DE
Fiscal Year End May 31
SIC 3843 - Dental Equipment and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2019
Q2
8/31/2019
Q1
5/31/2019
Q4
2/28/2019
Q3
11/30/2018
Q2
8/31/2018
Q1
5/31/2018
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8518086879181,1255841,205
Cash and cash equivalents8518086879181,1255841,205
Receivables1,2838591,4551,0771,2611,014800
Inventory, net of allowances, customer advances and progress billings2,1912,2062,1512,0802,1152,2082,179
Inventory2,1912,2062,1512,0802,1152,2082,179
Other undisclosed current assets186242202254187311300
Total current assets:4,5114,1144,4954,3294,6884,1174,484
Noncurrent Assets
Operating lease, right-of-use asset1,8241,879  
Property, plant and equipment304324351346349362351
Intangible assets, net (including goodwill)110114107959810599
Intangible assets, net (excluding goodwill)110114107959810599
Other noncurrent assets125129127122120117113
Deferred tax assets, net  10
Other undisclosed noncurrent assets165165165175175175165
Total noncurrent assets:2,5282,610750739741759739
TOTAL ASSETS:7,0396,7245,2455,0685,4294,8765,223
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,3459441,038890800583687
Accounts payable1,345944     
Employee-related liabilities  227224216215210
Other undisclosed accounts payable and accrued liabilities  811666584368477
Debt200195     
Other undisclosed current liabilities439230227224216215210
Total current liabilities:1,9841,3691,2641,1131,017798897
Noncurrent Liabilities
Long-term debt and lease obligation1,6781,731     
Operating lease, liability1,6781,731  
Total noncurrent liabilities:1,6781,731     
Total liabilities:3,6633,1001,2641,1131,017798897
Stockholders' equity
Stockholders' equity attributable to parent3,3763,6243,9813,9544,4124,0784,326
Common stock788782774747743716711
Common stock, share subscribed but unissued, subscriptions receivable(16)  (6)   
Additional paid in capital23,22322,97522,83022,04921,82321,03520,844
Accumulated other comprehensive loss(42)(40)(37)(34)(32)(27)(26)
Accumulated deficit(20,578)(20,093)(19,587)(18,801)(18,123)(17,645)(17,194)
Stockholders' equity note, subscriptions receivable      (9)
Total stockholders' equity:3,3763,6243,9813,9544,4124,0784,326
TOTAL LIABILITIES AND EQUITY:7,0396,7245,2455,0685,4294,8765,223

Income statement (P&L) ($ in thousands)

11/30/2019
Q2
8/31/2019
Q1
5/31/2019
Q4
2/28/2019
Q3
11/30/2018
Q2
8/31/2018
Q1
5/31/2018
Q4
Revenues1,5961,1941,1661,2611,5011,2731,130
Cost of revenue(1,128)(827)(985)(895)(1,093)(936)(862)
Gross profit:469367181366408337268
Operating expenses(959)(877)(946)(1,073)(894)(792)(912)
Operating loss:(490)(510)(765)(707)(486)(455)(644)
Nonoperating income44429938
Investment income, nonoperating44429938
Interest and debt expense(0)    (0) 
Other undisclosed income from continuing operations before equity method investments, income taxes     0 
Loss from continuing operations before income taxes:(485)(505)(761)(679)(477)(452)(636)
Income tax expense (1)     
Other undisclosed loss from continuing operations  (24)   (32)
Net loss:(485)(506)(785)(679)(477)(452)(668)
Other undisclosed net income attributable to parent0      
Net loss available to common stockholders, diluted:(485)(506)(785)(679)(477)(452)(668)

Comprehensive Income ($ in thousands)

11/30/2019
Q2
8/31/2019
Q1
5/31/2019
Q4
2/28/2019
Q3
11/30/2018
Q2
8/31/2018
Q1
5/31/2018
Q4
Net loss:(485)(506)(785)(679)(477)(452)(668)
Comprehensive loss:(485)(506)(785)(679)(477)(452)(668)
Other undisclosed comprehensive loss, net of tax, attributable to parent(2)(3)(3)(2)(4)(1)(4)
Comprehensive loss, net of tax, attributable to parent:(487)(510)(788)(680)(482)(453)(672)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: